The Drug Class Reviews were conducted in a transparent and open fashion. Stakeholder input (public, patient advocacy groups, individual patients, healthcare providers, industry, policy makers, etc.) was sought at various stages to ensure a rigorous review, including Committee Membership, input on Comprehensive Research Plans and Draft Report and Recommendations, Workshop Session and Evidence Submission Packages. Public posting ensures that the final reports are transparent, accessible and credible; we want to ensure that the final report reflects the needs of the public.
Find out more information about our drug class review process: